{"id":"CHEMBL1087","canonicalSmiles":"Cc1cccc(C)c1NC(=O)C1CCCCN1C","inchiKey":"INWLQCZOYSRPNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPIVACAINE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["APF-135","Carbocaine","Mepivacaine","Polocaine","Polocaine-Mpf"],"crossReferences":{"DailyMed":["mepivacaine%20hydrochloride"],"Wikipedia":["Mepivacaine"],"drugbank":["DB00961"],"chEBI":["6759"]},"childChemblIds":["CHEMBL1200440"],"count":2,"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_1001139","EFO_0009540","EFO_0010582","EFO_0004269","EFO_1000786","EFO_0004616","MONDO_0004001","EFO_0003843","MONDO_0008315","EFO_0000537"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and has 2 investigational indications."}
{"id":"CHEMBL1093","canonicalSmiles":"CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC","inchiKey":"QTGIAADRBBLJGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTICAINE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["40 045","40-045","Articaine","Carticaine","HOE 045","HOE-045","Septocaine"],"crossReferences":{"DailyMed":["articaine%20hydrochloride"],"Wikipedia":["Articaine"],"drugbank":["DB09009"]},"childChemblIds":["CHEMBL1200819"],"count":3,"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_1001139","EFO_1001216","EFO_0000649","EFO_0003843","EFO_1002048"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 3 investigational indications."}
{"id":"CHEMBL1095283","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)Oc3ccccc3)c3ccccc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"NZDASSHFKWDBBU-KVMCETHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBENICILLIN PHENYL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carfecillin"],"crossReferences":{"Wikipedia":["Carfecillin"],"drugbank":["DB13506"],"chEBI":["3414"]},"childChemblIds":["CHEMBL2105996"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1102","canonicalSmiles":"CCC1(c2ccccc2)CCC(=O)NC1=O","inchiKey":"JMBQKKAJIKAWKF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTETHIMIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doriden","Glutethimide"],"synonyms":["Glutethimide"],"crossReferences":{"PubChem":["144205194","170465223","29215340"],"Wikipedia":["Glutethimide"],"drugbank":["DB01437"],"chEBI":["5439"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL111654","canonicalSmiles":"Sc1nc2ccccc2s1","inchiKey":"YXIWHUQXZSMYRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-MERCAPTOBENZOTHIAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Mercaptobenzothiazole","2-Mercaptobenzothioazole","Benzothiazole-2-Thiol"],"crossReferences":{"PubChem":["124891199","124891200","144207000","144213977","17389836","26747389","26753081","29215119"],"drugbank":["DB11496"],"chEBI":["34292"]},"childChemblIds":["CHEMBL3182456"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL112322","canonicalSmiles":"CN(C)c1ccc(C(=O)O)cc1","inchiKey":"YDIYEOMDOWUDTJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Dimethylamino-Benzoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Dimethylamino-Benzoic Acid"],"crossReferences":{"drugbank":["DB08748"]},"childChemblIds":["CHEMBL1762663"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL114","canonicalSmiles":"CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1","inchiKey":"QWAXKHKRTORLEM-UGJKXSETSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SAQUINAVIR","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fortovase","Invirase"],"synonyms":["Invirase","RO 31-8959/000","Ro-31-8959","SCH-52852","Saquinavir"],"crossReferences":{"DailyMed":["saquinavir%20mesylate"],"PubChem":["49666064","50105601"],"Wikipedia":["Saquinavir"],"drugbank":["DB01232"],"chEBI":["63621"]},"childChemblIds":["CHEMBL282042"],"count":5,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for viral disease and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1153","canonicalSmiles":"C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2C[C@@H](O)[C@]2(C)[C@@H](C3=CC(=O)OC3)CC[C@]12O","inchiKey":"SHIBSTMRCDJXLN-KCZCNTNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIGOXIGENIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124882990","251919877","26754265","56463065"],"Wikipedia":["Digoxigenin"],"drugbank":["DB03671"],"chEBI":["42098"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160818","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)cc1CO","inchiKey":"WEBVWKFGRVLCNS-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160818","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03846"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1164032","canonicalSmiles":"Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1.O=S(=O)(O)O","inchiKey":"LEYHUWYWUPRPEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PALOSURAN SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL567303","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200403","canonicalSmiles":"CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1.Cl","inchiKey":"BFUBEWDYLSDZEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUCLIZINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201271","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bucladin-S"],"synonyms":["UCB-4445"],"crossReferences":{"PubChem":["542471"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200419","canonicalSmiles":"CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2.Cl","inchiKey":"GQWNECFJGBQMBO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MOLINDONE HYDROCHLORIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL460","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Moban","Molindone hydrochloride"],"synonyms":["EN-1733A","Molindone hydrochloride"],"crossReferences":{"DailyMed":["molindone%20hydrochloride"],"PubChem":["144204130","170465047","26753596","49648854"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200444","canonicalSmiles":"CC(=O)O.CC(C)(C)NCC(O)c1ccc(O)c(CO)n1","inchiKey":"QSXMZJGGEWYVCN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRBUTEROL ACETATE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1094966","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Maxair"],"synonyms":["CP-24,314-14","CP-24314-14","Pirbuterol acetate"],"count":1,"approvedIndications":["EFO_0000270"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986 and is indicated for asthma."}
{"id":"CHEMBL1200487","canonicalSmiles":"C=C(CC)C(=O)c1ccc(OCC(=O)[O-])c(Cl)c1Cl.[Na+]","inchiKey":"CWCSCNSKBSCYCS-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHACRYNATE SODIUM","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL456","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Edecrin","Ethacrynate sodium"],"synonyms":["Ethacrynate sodium"],"crossReferences":{"DailyMed":["ethacrynate%20sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967."}
{"id":"CHEMBL1200648","canonicalSmiles":"C=CC[N+]1([C@H]2C[C@H]3[C@@H]4CC[C@H]5C[C@H](O)[C@@H](N6CCOCC6)C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2OC(C)=O)CCCC1.[Br-]","inchiKey":"OYTJKRAYGYRUJK-FMCCZJBLSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ROCURONIUM BROMIDE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201244","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Esmeron","Rocuronium bromide","Zemuron"],"synonyms":["ORG 9426","ORG-9426","Rocuronium bromide"],"crossReferences":{"DailyMed":["rocuronium%20bromide"],"PubChem":["144205990"],"chEBI":["8885"]},"count":2,"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["HP_0002093","HP_0003418","EFO_0009492"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 2 investigational indications."}
{"id":"CHEMBL1200699","canonicalSmiles":"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O","inchiKey":"XQTWDDCIUJNLTR-CVHRZJFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXYCYCLINE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1433","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doxychel","Doxycycline","Monodox","Oracea","Vibramycin"],"synonyms":["Doxycycline","Doxycycline anhydrous","Doxycycline hydrochloride","Doxycycline monohydrate","GS-3065"],"crossReferences":{"chEBI":["60648"]},"count":59,"approvedIndications":["EFO_0003106","EFO_1000760","EFO_0003894"],"linkedTargets":{"rows":["ENSG00000196611","ENSG00000137745","ENSG00000118113","ENSG00000137673"],"count":4},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000842","EFO_0000365","EFO_0007486","EFO_0000756","EFO_0000249","EFO_0009536","EFO_0007272","EFO_0005952","EFO_0003102","Orphanet_85443","EFO_1001951","EFO_0007205","EFO_0000771","EFO_1001459","EFO_0002506","EFO_0000096","EFO_0000544","EFO_0007357","EFO_1000961","EFO_0008517","EFO_1000785","MONDO_0002635","EFO_0002618","EFO_0007504","EFO_0002687","EFO_1000906","HP_0000964","MONDO_0022113","EFO_1001466","EFO_0000701","Orphanet_3389","EFO_0000662","Orphanet_558","EFO_0000384","EFO_0003878","EFO_1000760","MP_0001914","EFO_1001388","EFO_0007460","MONDO_0100096","EFO_0007430","HP_0000130","EFO_1001177","EFO_0000574","EFO_0009659","EFO_1001051","EFO_0000341","EFO_1001312","Orphanet_314701","EFO_0009637","EFO_0004214","EFO_0001365","EFO_1001984","EFO_0000768","EFO_0002913","Orphanet_586","EFO_0000274","Orphanet_85451","EFO_0005622","EFO_0008510","EFO_0009425","HP_0002013","EFO_0000778","EFO_0000616","EFO_1001788","HP_0001945","EFO_1001875","EFO_0003770","EFO_0000319","Orphanet_271861","HP_0001250","EFO_0003894","EFO_0003843","EFO_1000941","EFO_0003060","EFO_0000311","EFO_0003106","EFO_0003885","EFO_0000649","EFO_0000764","EFO_0000199","EFO_1000781","EFO_0000612","MONDO_0043510","EFO_0001067","MONDO_0024880","EFO_0007480","EFO_0003895"],"count":89},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and has 3 approved and 56 investigational indications."}
{"id":"CHEMBL1200734","canonicalSmiles":"CC(C)CN(C[C@@H](OP(=O)([O-])[O-])[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1.[Ca+2]","inchiKey":"PMDQGYMGQKTCSX-HQROKSDRSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSAMPRENAVIR CALCIUM","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1664","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fosamprenavir calcium","Lexiva","Telzir"],"synonyms":["Fosamprenavir calcium","Fosamprenavir calcium salt","GW 433908G","GW-433908G"],"crossReferences":{"DailyMed":["fosamprenavir%20calcium"],"PubChem":["144206185"]},"count":1,"approvedIndications":["EFO_0000764"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003 and is indicated for hiv infection."}
{"id":"CHEMBL1200982","canonicalSmiles":"CCC(C)C1(CC)C(=O)[N-]C(=O)NC1=O.[Na+]","inchiKey":"QORQZMBCPRBCAB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTABARBITAL SODIUM","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL449","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Butabarb","Butabarbital","Butabarbital sodium","Butalan","Buticaps","Butisol sodium","Sarisol","Sarisol no. 1","Sarisol no. 2","Sodium butabarbital"],"synonyms":["Butabarbital sodium","Secbutabarbital sodium"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1939."}
{"id":"CHEMBL1201149","canonicalSmiles":"Cl.O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5","inchiKey":"RHBRMCOKKKZVRY-ITLPAZOVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NALTREXONE HYDROCHLORIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL19019","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adepend","Depade","Nalorex","Naltrexone hydrochloride","Opizone","Revia"],"synonyms":["EN-1639A","EN-1639A (AS HYDROCHLORIDE)","Naltrexone hydrochloride"],"crossReferences":{"DailyMed":["naltrexone%20hydrochloride"],"PubChem":["56422210","855955"]},"count":3,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000116329","ENSG00000082556","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0005203","HP_0012532","EFO_0005611","HP_0100716","EFO_0003843"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for pain and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201180","canonicalSmiles":"O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl.OCCN1CCCC1","inchiKey":"DCERVXIINVUMKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DICLOFENAC EPOLAMINE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL139","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Flector","Flector Patch","Licart"],"synonyms":["Diclofenac epolamine"],"crossReferences":{"DailyMed":["diclofenac%20epolamine"],"chEBI":["48296"]},"count":4,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0009582","MONDO_0007254","EFO_1000652","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for pain and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201264","canonicalSmiles":"CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21","inchiKey":"GZHFODJQISUKAY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHANTHELINE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methantheline","Methanthelinium"],"crossReferences":{"PubChem":["11112123"],"Wikipedia":["Methantheline"],"drugbank":["DB00940"],"chEBI":["6817"]},"childChemblIds":["CHEMBL1200988"],"count":2,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000113749"],"count":1},"linkedDiseases":{"rows":["EFO_0010282","HP_0000011"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1951 and is indicated for gastrointestinal disease and has 1 investigational indication."}
{"id":"CHEMBL1201317","canonicalSmiles":"O=P(O)(O)OCC(Cl)(Cl)Cl","inchiKey":"YYQRGCZGSFRBAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICLOFOS","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Triclofos"],"crossReferences":{"Wikipedia":["Triclofos"],"drugbank":["DB06753"],"chEBI":["9695"]},"childChemblIds":["CHEMBL1200789"],"linkedTargets":{"rows":["ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000187730","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000022355","ENSG00000182256","ENSG00000102287","ENSG00000094755","ENSG00000268089","ENSG00000163285","ENSG00000113327","ENSG00000186297","ENSG00000163288"],"count":16},"linkedDiseases":{"rows":["EFO_0003758"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201326","canonicalSmiles":"[Rb]","inchiKey":"IGLNJRXAVVLDKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUBIDIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rubidium"],"crossReferences":{"drugbank":["DB11346"],"chEBI":["33322"]},"childChemblIds":["CHEMBL4297424"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1201519","drugType":"Unknown","blackBoxWarning":false,"name":"VITAMIN K","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Vitamin k"],"crossReferences":{"DailyMed":["vitamin%20k"]},"count":10,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 10 investigational indications."}
{"id":"CHEMBL120293","canonicalSmiles":"C=CCn1c(=O)c2[nH]c(Cc3ccc(NC(C)=O)cc3)nc2n(CCCC)c1=O","inchiKey":"XFOWZKUTPKXWIE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL120293","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03267"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1222017","canonicalSmiles":"CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](NC(C)=O)[C@H]3O)[C@H](NC(C)=O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"WZZVUHWLNMNWLW-VFCSDQTKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIACETYLCHITOTRIOSE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04194"],"chEBI":["71404"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230016","canonicalSmiles":"CC(C)C[C@@H](N)C(=O)N1CCC[C@H]1C(=O)NCc1ccc(C(=N)N)cc1","inchiKey":"XFNMDMGNNKIXBT-CVEARBPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230016","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06996"]},"childChemblIds":["CHEMBL3423208"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230813","canonicalSmiles":"OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O","inchiKey":"HFHDHCJBZVLPGP-RWMJIURBSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ALFADEX","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-cyclodextrin","Alfadex","Alpha cyclodextrin","NSC-269470"],"crossReferences":{"PubChem":["144204566","144208450","144210622","17389189","26752792","49674568"],"drugbank":["DB01909"],"chEBI":["40585"]},"count":1,"description":"Oligosaccharide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1231350","canonicalSmiles":"O=C(O)c1cc2cc(O)ccc2cc1O","inchiKey":"QMWOUSYSNFCKAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231350","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04641"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231913","canonicalSmiles":"Clc1ccc(-c2cnc[nH]2)cc1","inchiKey":"DVKIFCXVRCGAEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231913","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02974"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)[O-])c4)C3)[C@H](C)[C@H]12.[Na+]","inchiKey":"ZXNAQFZBWUNWJM-HRXMHBOMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ERTAPENEM SODIUM","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1359","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Invanz"],"synonyms":["Ertapenem sodium","Ertapenem sodium salt","Invanz","L-749345","MK-0826","MK-826"],"crossReferences":{"DailyMed":["ertapenem%20sodium"],"chEBI":["60070"]},"count":4,"approvedIndications":["EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for infection and has 3 investigational indications."}
{"id":"CHEMBL1232243","canonicalSmiles":"O=C(O)c1cc(I)cc(I)c1O","inchiKey":"DHZVWQPHNWDCFS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232243","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04674"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233239","canonicalSmiles":"CC(C)CCN(C[C@@H](O)[C@@H]1Cc2ccc(cc2)OCCCC(=O)N[C@@H](CC(N)=O)C(=O)N1)S(=O)(=O)c1ccccc1","inchiKey":"HOUHLOFMBSYNBO-KKUQBAQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233239","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02411"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234578","canonicalSmiles":"Nc1cccc2cc(S(=O)(=O)O)ccc12","inchiKey":"UWPJYQYRSWYIGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234578","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["89853209"],"drugbank":["DB08238"],"chEBI":["44188"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235136","canonicalSmiles":"O=C(NO)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"OHQFMJPEBPCIEQ-JJYYJPOSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235136","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1255752","canonicalSmiles":"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.Cl","inchiKey":"VCOPKZDMFOGRTQ-GSPXQYRGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-Bromocriptine","maximumClinicalTrialPhase":0,"parentId":"CHEMBL493","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(+)-Bromocriptine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256723","canonicalSmiles":"C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl","inchiKey":"RUYHIJHUVHIMIR-CVHRZJFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXYCYCLINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1433","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Doxycycline HCl"],"crossReferences":{"PubChem":["144204117","170465097"],"chEBI":["652992"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1269102","canonicalSmiles":"CC(C)C[C@@H]1NC(=O)[C@@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC1=O","inchiKey":"VYCMAAOURFJIHD-AOYLRGCGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BQ-123","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BQ-123","BQ123","Bq-123"],"crossReferences":{"Wikipedia":["BQ-123"]},"count":4,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL12856","canonicalSmiles":"Nc1cc(-c2ccncc2)c[nH]c1=O","inchiKey":"RNLQIBCLLYYYFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INAMRINONE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inocor"],"synonyms":["Amrinone","Inamrinone","WIN 40680"],"crossReferences":{"PubChem":["11112811","11533005","124882647","144205663","144212164","170465367","26750001","26757798","56424028"],"Wikipedia":["Amrinone"],"drugbank":["DB01427"]},"childChemblIds":["CHEMBL2096642"],"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000172572"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and is indicated for cardiovascular disease."}
{"id":"CHEMBL1359","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)Nc4cccc(C(=O)O)c4)C3)[C@H](C)[C@H]12","inchiKey":"JUZNIMUFDBIJCM-ANEDZVCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERTAPENEM","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ertapenem","Invanz"],"crossReferences":{"DailyMed":["ertapenem%20sodium"],"Wikipedia":["Ertapenem"],"drugbank":["DB00303"],"chEBI":["404903"]},"childChemblIds":["CHEMBL1232"],"count":10,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for bacterial disease and has 9 investigational indications."}
{"id":"CHEMBL1396177","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O.CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O.c1ccc(CNCCNCc2ccccc2)cc1","inchiKey":"BBTOYUUSUQNIIY-ANPZCEIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENICILLIN V BENZATHINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL615","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzathine phenoxymethylpenicillin","Penicillin benzathine phenoxymethyl","Penicillin v benzathine"],"crossReferences":{"DrugCentral":["4440"],"PubChem":["11112967"],"chEBI":["31973"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1401508","canonicalSmiles":"COc1cc(C2Oc3cc(C4Oc5cc(O)cc(O)c5C(=O)C4O)ccc3OC2CO)ccc1O","inchiKey":"SEBFKMXJBCUCAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SILIBININ","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Silibinin","Silybin","Silymarin"],"crossReferences":{"DrugCentral":["2443"],"PubChem":["124883412","26747209","855643"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1437301","canonicalSmiles":"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.Cl","inchiKey":"OWNWYCOLFIFTLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1437301","maximumClinicalTrialPhase":0,"parentId":"CHEMBL714","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26747849"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1469737","canonicalSmiles":"CC(C)(S)[C@@H](N)C(=O)O.Cl","inchiKey":"CZDHUFYOXKHLME-DFWYDOINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1469737","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1430","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["855797"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1519","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21","inchiKey":"VXFJYXUZANRPDJ-WTNASJBWSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRANDOLAPRIL","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gopten","Mavik","Odrik","Trandolapril"],"synonyms":["Indolapril","RU 44570","RU-44570","Trandolapril"],"crossReferences":{"DailyMed":["trandolapril"],"PubChem":["144205006","144206703","90340949"],"Wikipedia":["Trandolapril"],"drugbank":["DB00519"]},"count":3,"approvedIndications":["EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0000319","EFO_0000266","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for hypertension and cardiovascular disease and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1615025","canonicalSmiles":"Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21","inchiKey":"RCLQNICOARASSR-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-733","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAK-733","TAK733","Tak 733","Tak-733"],"crossReferences":{"drugbank":["DB12241"]},"count":1,"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0002617"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1618","canonicalSmiles":"Cn1nnnc1SCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)[C@H](OC=O)c3ccccc3)[C@H]2SC1.[Na+]","inchiKey":"ICZOIXFFVKYXOM-YCLOEFEOSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFAMANDOLE NAFATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201218","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mandol"],"synonyms":["106223","Cefamandole Nafate sodium","Cefamandole nafate","Cephamandole nafate","NSC-299588"],"crossReferences":{"chEBI":["3481"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1978 and has 1 investigational indication."}
{"id":"CHEMBL16502","canonicalSmiles":"CC(C)(C)O","inchiKey":"DKGAVHZHDRPRBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERT-BUTANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Tert-Butyl_alcohol"],"drugbank":["DB03900"],"chEBI":["45895"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1650317","canonicalSmiles":"CCC(C)(C)C(=O)[O-].[Na+]","inchiKey":"OOPXYEYPPHJHSE-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM 2,2-DIMETHYLBUTYRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL286013","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HQK-1001","Hqk-1001","Sodium 2,2 dimethylbutyrate","Sodium 2,2-dimethylbutyrate"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1689772","canonicalSmiles":"CN(C)c1cc(CNCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O","inchiKey":"JEECQCWWSTZDCK-IQZGDKDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMADACYCLINE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amadacycline","BAY 73-6944","Omadacycline","PTK 0796"],"crossReferences":{"DailyMed":["omadacycline%20tosylate"],"drugbank":["DB12455"]},"childChemblIds":["CHEMBL3942449","CHEMBL3954447","CHEMBL2103854"],"count":4,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for bacterial disease and has 3 investigational indications."}
{"id":"CHEMBL1735","canonicalSmiles":"CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O.O=S(=O)(O)O","inchiKey":"NUBQKPWHXMGDLP-BDEHJDMKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDINAVIR SULFATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL115","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Crixivan"],"synonyms":["Crixivan","Indinavir sulfate","Indinavir sulfate ethanolate","L-735,524","L-735524","MK-639"],"crossReferences":{"DailyMed":["indinavir%20sulfate"],"PubChem":["144205240","144212732","170465228","49681566"],"chEBI":["5899"]},"count":7,"approvedIndications":["EFO_0000764"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for hiv infection and has 6 investigational indications."}
{"id":"CHEMBL1743050","drugType":"Antibody","blackBoxWarning":false,"name":"OLOKIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDP-6038","CDP6038","Olokizumab"],"count":3,"linkedTargets":{"rows":["ENSG00000136244"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002506","MONDO_0100096","EFO_0000384"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1788132","canonicalSmiles":"CC(Oc1c(Cl)cccc1Cl)C1=NCCN1.Cl","inchiKey":"DWWHMKBNNNZGHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOFEXIDINE HYDROCHLORIDE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL17860","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Britlofex","Lofexidine","Lucemyra"],"synonyms":["Lofexidine hydrochloride","MDL 14,042","MDL-14042"],"crossReferences":{"DailyMed":["lofexidine%20hydrochloride"]},"count":2,"approvedIndications":["EFO_0005800"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0005800","EFO_0005611"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for substance withdrawal syndrome and has 1 investigational indication."}
{"id":"CHEMBL1796999","canonicalSmiles":"C1CC1","inchiKey":"LVZWSLJZHVFIQJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOPROPANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyclopropane","Trimethylene"],"crossReferences":{"Wikipedia":["Cyclopropane"],"drugbank":["DB13984"],"chEBI":["30365"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1797128","canonicalSmiles":"C[S+](C)CC[C@H](N)C(=O)O.[Cl-]","inchiKey":"MYGVPKMVGSXPCQ-JEDNCBNOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLMETHIONINE SULFONIUM CHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL45024","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methiosulfonium chloride","Methylmethionine sulfonium chloride","Vitamin U"],"crossReferences":{"drugbank":["DB13250"],"chEBI":["6884"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL18","canonicalSmiles":"CCOc1ccc2nc(S(N)(=O)=O)sc2c1","inchiKey":"OUZWUKMCLIBBOG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHOXZOLAMIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardrase","Ethamide"],"synonyms":["Ethoxzolamide"],"crossReferences":{"PubChem":["144204399","170465083","56422188","855751"],"Wikipedia":["Ethoxzolamide"],"drugbank":["DB00311"],"chEBI":["101096"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL185918","canonicalSmiles":"Oc1ccc2nc(-c3cccc4c(O)cccc34)oc2c1","inchiKey":"JHOZVRGNIYFYHE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL185918","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07009"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1870768","canonicalSmiles":"CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1.O=C(O)/C=C\\C(=O)O","inchiKey":"SWECWXGUJQLXJF-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHINDENE MALEATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL22108","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fenostil","Forhistal maleate"],"synonyms":["Dimethindene maleate","Dimetindene maleate","NSC-107677","SU-6518"],"crossReferences":{"PubChem":["92764835"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL188","canonicalSmiles":"Cc1c(C(=O)c2cccc3ccccc23)c2cccc3c2n1[C@H](CN1CCOCC1)CO3","inchiKey":"HQVHOQAKMCMIIM-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WIN-552122","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["WIN-55212-2"],"crossReferences":{"PubChem":["124881900","26754855","26754856","50110805","50110806","90341664"],"Wikipedia":["WIN_55,212-2"],"drugbank":["DB13950"],"chEBI":["73295"]},"childChemblIds":["CHEMBL1222317"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1905872","canonicalSmiles":"CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)[O-].[Na+]","inchiKey":"APSBXTVYXVQYAB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DOCUSATE SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1477036","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Audinorm","Clear ear","Colace","Correctol stool softener laxative","D-s-s","Dialose","Dioctyl","Docusol","Docusol 100","Doxinate","Dulcoease","Fletchers' enemette","Klyx","Modane soft","Molcer","Molofac","Norgalax","Soliwax","Waxsol"],"synonyms":["Dioctyl disodium sulfosuccinate","Dioctyl sodium sulfosuccinate","Docusate sodium","E480","Sodium dioctyl sulfosuccinate"],"crossReferences":{"PubChem":["144205640","144207018","144208540","144210814","26757557"],"Wikipedia":["Dioctyl_sodium_sulfosuccinate"]},"count":3,"approvedIndications":["EFO_0004272","HP_0002019","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved indications."}
{"id":"CHEMBL1933350","canonicalSmiles":"CCC[C@H](c1ccc(C(=O)NCCC(=O)O)cc1)[C@H](c1ccc(Cl)cc1)c1c[nH]c2c(F)cc(C)cc12","inchiKey":"FYRJJCYFYLLOSC-LXFBAYGMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-3577","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-3577"],"crossReferences":{"drugbank":["DB14957"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1980535","canonicalSmiles":"CC(=O)O[C@H]1CC(C)(C)C(=C=C/C(C)=C/C=C/C=C/C=C(C)/C=C2/C=C(/C=C/[C@@]34O[C@]3(C)C[C@@H](O)CC4(C)C)C(=O)O2)[C@](C)(O)C1","inchiKey":"UYRDHEJRPVSJFM-VSWVFQEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1980535","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["518143"],"drugbank":["DB03001"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2028850","canonicalSmiles":"N=C(N)NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)C(=O)O","inchiKey":"QURWXBZNHXJZBE-SKXRKSCCSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ICATIBANT","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["HOE-140","Icatibant"],"crossReferences":{"DailyMed":["icatibant%20acetate"],"drugbank":["DB06196"]},"childChemblIds":["CHEMBL2028852"],"count":5,"approvedIndications":["Orphanet_91378"],"linkedTargets":{"rows":["ENSG00000168398"],"count":1},"linkedDiseases":{"rows":["Orphanet_68380","MP_0001845","MONDO_0100096","EFO_0003144","EFO_1000999","EFO_0005532","Orphanet_91378"],"count":7},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for hereditary angioedema and has 4 investigational indications."}
{"id":"CHEMBL207675","canonicalSmiles":"C[C@@H]1CC[C@H]2[C@@H](C)[C@H](OC(=O)CCC(=O)[O-])O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4.[Na+]","inchiKey":"ZISJLHQNEVGTIU-RFEYTNPVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM ARESUNATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL361497","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sodium Aresunate","Sodium Artesunate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103736","canonicalSmiles":"CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.O.O.[Ca+2]","inchiKey":"LZPBLUATTGKZBH-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":true,"name":"FENOPROFEN CALCIUM","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1297","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fenoprofen calcium","Nalfon"],"synonyms":["69323","Fenoprofen calcium"],"crossReferences":{"DailyMed":["fenoprofen%20calcium"],"chEBI":["5005"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104591","canonicalSmiles":"CC(CCN1CCOCC1)OC(=O)C1(c2ccccc2)CCOCC1","inchiKey":"RDEOYUSTRWNWLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEDRILATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fedrilate","UCB 3928"],"crossReferences":{"drugbank":["DB13825"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105395","canonicalSmiles":"OCCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1","inchiKey":"LUMKNAVTFCDUIE-VHXPQNKSSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OSPEMIFENE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Osphena","Senshio"],"synonyms":["FC-1271","FC-1271A","Ospemifene"],"crossReferences":{"DailyMed":["ospemifene"],"Wikipedia":["Ospemifene"],"drugbank":["DB04938"],"chEBI":["73275"]},"count":3,"approvedIndications":["HP_0030016"],"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0004714","EFO_0000512","EFO_1000096","HP_0030016"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for dyspareunia and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105499","canonicalSmiles":"Cc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1","inchiKey":"DZQVFHSCSRACSX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAPERIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isosulfamerazine","Sulfaperin"],"crossReferences":{"PubChem":["170466624"],"drugbank":["DB13320"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105662","canonicalSmiles":"CS(=O)(=O)O.O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1","inchiKey":"QKVKOFVWUHNEBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LOMITAPIDE MESYLATE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL354541","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Juxtapid"],"synonyms":["AEGR-733","AEGR-733 MESYLATE","BMS-201038","BMS-201038-04","Lomitapide mesilate","Lomitapide mesylate"],"crossReferences":{"DailyMed":["lomitapide%20mesylate"],"chEBI":["72299"]},"count":4,"approvedIndications":["Orphanet_391665","EFO_0004911"],"linkedTargets":{"rows":["ENSG00000138823"],"count":1},"linkedDiseases":{"rows":["HP_0003124","Orphanet_391665","EFO_0003774","EFO_0004911"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for homozygous familial hypercholesterolemia and familial hypercholesterolemia and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105694","canonicalSmiles":"COCC(=O)[C@@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C","inchiKey":"JVBGZFRPTRKSBB-MJBQOYBXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELAPRISTONE ACETATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Proellex","Proellextm","Progenta"],"synonyms":["CDB-4124","RU 44675","RU-44675","Telapristone acetate","ZPV-200"],"crossReferences":{"drugbank":["DB05253"]},"count":6,"linkedTargets":{"rows":["ENSG00000082175"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0010269","EFO_0000731","EFO_0001065","EFO_0001421","MONDO_0007254"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2105704","canonicalSmiles":"COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O.CS(=O)(=O)O","inchiKey":"HWLFIUUAYLEFCT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LENVATINIB MESYLATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1289601","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lenvima"],"synonyms":["E-7080 MESYLATE","E7080","E7080 MESYLATE","Lenvatinib mesilate","Lenvatinib mesylate","Lenvatinib methanesulfonate"],"crossReferences":{"DailyMed":["lenvatinib%20mesylate"],"chEBI":["85995"]},"count":6,"approvedIndications":["MONDO_0002108","EFO_0002892"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002892","MONDO_0002108","EFO_0005221","EFO_0003060","EFO_0002617","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for thyroid cancer and thyroid carcinoma and has 4 investigational indications."}
{"id":"CHEMBL2107212","canonicalSmiles":"CN(CC(O)CO)C(=O)c1c(I)c(NC(=O)C(CO)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I","inchiKey":"YLPBXIKWXNRACS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOBITRIDOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iobitridol"],"crossReferences":{"drugbank":["DB12407"],"chEBI":["31701"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107375","canonicalSmiles":"Cl.N=C(N)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1","inchiKey":"PIGYMBULXKLTCJ-UHSSARMYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARIBAVIRIN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2111108","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Viramidine"],"synonyms":["Taribavirin hydrochloride"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2107832","canonicalSmiles":"O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F","inchiKey":"VIUAUNHCRHHYNE-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Msc1936369a; as703026; emd 1036239"],"synonyms":["AS 703026","AS-703026","AS703026","As-703026","EMD 1036239","EMD-1036239","G-02443714","MSC-1936369A","MSC-1936369B","MSC1936369A","Pimasertib"],"crossReferences":{"drugbank":["DB14904"]},"childChemblIds":["CHEMBL4297676"],"count":9,"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_1000044","EFO_0000756","MONDO_0008170","EFO_0000182","EFO_0000389","MONDO_0007254","EFO_0000222","EFO_0003060","EFO_1001951","EFO_0000311"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2107962","drugType":"Unknown","blackBoxWarning":false,"name":"POLIOVIRUS VACCINE INACTIVATED","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Poliomyelitis vaccine","Poliovirus vaccine inactivated"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108315","drugType":"Protein","blackBoxWarning":false,"name":"SOMATROPIN PEGOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NNC-126-0083","NNC-1260083","NNC126-0083","Somatropin pegol"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108718","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"SEMULOPARIN SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVE-5026","Semuloparin sodium"],"count":2,"linkedTargets":{"rows":["ENSG00000117601"],"count":1},"linkedDiseases":{"rows":["EFO_0004286","HP_0004936"],"count":2},"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109172","drugType":"Small molecule","blackBoxWarning":false,"name":"DIGITALIS","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Digifortis","Digiglusin"],"synonyms":["Digitalis","Digitalis leaves","Digitalis purpurea","Digitalis purpurea leaf","Digitalis purpurea leaf extract"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109266","drugType":"Antibody","blackBoxWarning":false,"name":"AVE-9633","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVE-9633","Ave-9633","HUMY9-6"],"count":1,"linkedTargets":{"rows":["ENSG00000105383"],"count":1},"linkedDiseases":{"rows":["MONDO_0004643"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109425","drugType":"Antibody","blackBoxWarning":false,"name":"14G2A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["14G2A","14g2a"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109528","drugType":"Antibody","blackBoxWarning":false,"name":"FASINUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fasinumab","REGN-475","REGN475","SAR-164877","SAR164877"],"count":7,"linkedTargets":{"rows":["ENSG00000134259"],"count":1},"linkedDiseases":{"rows":["EFO_0002506","EFO_1000786","EFO_0004616","HP_0003419","EFO_0003766","HP_0003418","HP_0011868"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2109529","drugType":"Antibody","blackBoxWarning":false,"name":"MU-BC-1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Angiomab"],"synonyms":["MU-BC-1"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109584","drugType":"Antibody","blackBoxWarning":false,"name":"F16SIP 131I","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["F16SIP","F16sip 131i"],"count":1,"linkedTargets":{"rows":["ENSG00000041982"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109585","drugType":"Antibody","blackBoxWarning":false,"name":"LY-2382770","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2382770","LY2382770","Ly-2382770"],"count":1,"linkedTargets":{"rows":["ENSG00000105329"],"count":1},"linkedDiseases":{"rows":["EFO_0000401"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109589","drugType":"Antibody","blackBoxWarning":false,"name":"L19TNFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L19TNFA","L19tnfa"],"count":1,"linkedTargets":{"rows":["ENSG00000115414"],"count":1},"linkedDiseases":{"rows":["EFO_1001968","EFO_1001951"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110596","canonicalSmiles":"C=CCN1Cc2ccccc2-c2ccccc2C1","inchiKey":"NYGHGTMKALXFIA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZAPETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azapetine"],"crossReferences":{"drugbank":["DB13727"]},"childChemblIds":["CHEMBL2103986"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2111186","canonicalSmiles":"C=Cc1c(C)c2cc3nc(c(CC(=O)N[C@@H](CC(=O)O)C(=O)O)c4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CC)c(C)c4C(=O)O)[C@@H](CCC(=O)O)[C@@H]3C","inchiKey":"VSEIDZLLWQQJGK-WSUYNKMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALAPORFIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Talaporfin"],"crossReferences":{"drugbank":["DB11812"]},"childChemblIds":["CHEMBL2107806"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2152999","canonicalSmiles":"Cc1c(C)c2c(c(C)c1OCC(=O)O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2","inchiKey":"LCFWOFKPFDWYLR-CEFNRUSXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":".ALPHA.-TOCOPHERYLOXYACETIC ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-tocopheryloxyacetic acid","Alpha-tocopheryloxyacetic acid"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2153191","canonicalSmiles":"CCCSc1nc(N2CCC[C@@H](CC(=O)O)C2)ccc1C(=O)NC1CCCCC1","inchiKey":"NCDZABJPWMBMIQ-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-4017","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-4017","AZD4017","Azd 4017","Azd-4017"],"crossReferences":{"drugbank":["DB14875"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL219341","canonicalSmiles":"O=c1[nH]c(=O)c2nn[nH]c2[nH]1","inchiKey":"KVGVQTOQSNJTJI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"8-Azaxanthine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8-Azaxanthine"],"crossReferences":{"drugbank":["DB01875"],"chEBI":["40850"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2360079","canonicalSmiles":"CC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C(O)/C=C\\C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"NUKVZKPNSKJGBK-SPIKMXEPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETOPHENAZINE MALEATE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1085","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tindal"],"synonyms":["Acephenazine dimaleate","Acetophenazine maleate","SCH 6673"],"crossReferences":{"PubChem":["144206283"],"chEBI":["2402"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961."}
{"id":"CHEMBL243978","canonicalSmiles":"c1cn(-c2ccc(Oc3nccc(Oc4ccc5c(c4)OCO5)n3)cc2)cn1","inchiKey":"XPXGYINSBORUMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL243978","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07008"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL254193","canonicalSmiles":"N/N=c1/cc2c(n[nH]1)CCN(C(=O)c1ccccc1)C2","inchiKey":"ALAXZYHFVBSJKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENDRALAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Endralazine"],"crossReferences":{"Wikipedia":["Endralazine"],"drugbank":["DB13435"]},"childChemblIds":["CHEMBL1980706"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL254520","canonicalSmiles":"Cc1cc(C)cc(C(=O)N(NC(=O)c2ccc3c(c2C)OCCO3)C(C)(C)C)c1","inchiKey":"JGJACZABNQGPMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL254520","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07929"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL256528","canonicalSmiles":"C[C@H]1C[C@@H](C)CN(C(=O)c2cc(Br)ccc2NC(=O)CCC(=O)O)C1","inchiKey":"JSVSGWHGYIDZFX-TXEJJXNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL256528","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08581"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL271138","canonicalSmiles":"c1nc(N2CCOCC2)c2nc[nH]c2n1","inchiKey":"MEOMXKNIFWDDGZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL271138","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["7969883","862467"],"drugbank":["DB08780"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL273453","canonicalSmiles":"C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12","inchiKey":"PQSUYGKTWSAVDQ-ZVIOFETBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALDOSTERONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aldosterone","NSC-73856"],"crossReferences":{"PubChem":["26757653","56320630"],"Wikipedia":["Aldosterone"],"drugbank":["DB04630"],"chEBI":["27584"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275446","canonicalSmiles":"C/N=C(\\S)NCCSCc1[nH]cnc1C","inchiKey":"FPBPLBWLMYGIQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METIAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Metiamide","SK&F 92058"],"crossReferences":{"Wikipedia":["Metiamide"],"drugbank":["DB08805"],"chEBI":["6896"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL279433","canonicalSmiles":"N#Cc1ccc(Cn2cncc2CN2CCN(c3cccc(Cl)c3)C(=O)C2)cc1","inchiKey":"JNUGFGAVPBYSHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-778123","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-778123"],"crossReferences":{"drugbank":["DB07227"]},"childChemblIds":["CHEMBL4297396"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL280527","canonicalSmiles":"CCNc1cccnc1N1CCN(C(=O)c2cc3cc(OC)ccc3[nH]2)CC1","inchiKey":"UCPOMLWZWRTIAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATEVIRDINE MESYLATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atevirdine","Atevirdine mesylate","Atevirdine methanesulfonate","U-87201","U-87201E"],"crossReferences":{"Wikipedia":["Atevirdine"],"drugbank":["DB12264"]},"childChemblIds":["CHEMBL7264"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL285347","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)[O-])=C(SC3Cn4cnc[n+]4C3)[C@H](C)[C@H]12","inchiKey":"MRMBZHPJVKCOMA-YJFSRANCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIAPENEM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Biapenem","CL 186,815","CL-186815","L-627","LJ C10,627","LJ-C10627","LJC-10627"],"crossReferences":{"PubChem":["144205733"],"Wikipedia":["Biapenem"],"drugbank":["DB13028"],"chEBI":["3089"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL286939","canonicalSmiles":"N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)O","inchiKey":"DCWXELXMIBXGTH-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL286939","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01962"],"chEBI":["37788"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL28721","canonicalSmiles":"O=C(O)C(S)C(S)C(=O)O","inchiKey":"ACTRVOBWPAIOHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,3-Dimercapto-Succinic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,3-Dimercapto-Succinic Acid","2,3-Dimercaptosuccinic Acid","Meso-2,3-Dimercaptosuccinic Acid"],"crossReferences":{"PubChem":["49640648","57260145"],"drugbank":["DB14089"]},"childChemblIds":["CHEMBL1684992"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL291157","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2ccc(-c3ccncc3)cc21","inchiKey":"XBPZXDSZHPDXQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSOXACIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eradacin","Roxadyl"],"synonyms":["Acrosoxacin","Rosoxacin","WIN 35,213"],"crossReferences":{"Wikipedia":["Rosoxacin"],"drugbank":["DB00817"]},"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL3039498","canonicalSmiles":"CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1","inchiKey":"HZVLFTCYCLXTGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRAPIPRANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["423","AAT-007","CJ 023423","CJ-023","CJ-023423","Grapiprant","MR-10A7","MR10A7","RQ-00000007","RQ-7"],"crossReferences":{"drugbank":["DB12836"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL304552","canonicalSmiles":"Oc1ccc([C@H]2Sc3cc(O)ccc3O[C@H]2c2ccc(OCCN3CCCCC3)cc2)cc1","inchiKey":"TWZNCTCQAGRUGQ-RRPNLBNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL304552","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03742"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3104237","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CSSC[C@H](NC(=O)CN)C(=O)N[C@@H](CSSC[C@@H](C(N)=O)NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2","inchiKey":"KJQOYUHYAZGPIZ-PIJHVLQJSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL3104237","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05724"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137331","canonicalSmiles":"CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1","inchiKey":"FWLMVFUGMHIOAA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEFACTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Defactinib","PF-04554878","VS-6063","Vs-6063"],"crossReferences":{"drugbank":["DB12282"]},"childChemblIds":["CHEMBL3137305"],"count":6,"linkedTargets":{"rows":["ENSG00000120899","ENSG00000169398"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_1000044","EFO_0000770","MONDO_0008170","EFO_0002517","EFO_0001378","EFO_0003060","EFO_0000311","EFO_1001951"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3186534","canonicalSmiles":"N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1","inchiKey":"WPEWQEMJFLWMLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVOCERANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apatinib","Rivoceranib","YN968D1","YN968D1 FREE BASE"],"crossReferences":{"PubChem":["124955476"],"drugbank":["DB14765"]},"childChemblIds":["CHEMBL3545414"],"linkedTargets":{"rows":["ENSG00000128052"],"count":1},"linkedDiseases":{"rows":["MONDO_0003060","EFO_0003869","EFO_0003891","EFO_0000637","EFO_0000365","EFO_0000756","EFO_0000681","EFO_0000571","EFO_1001951","EFO_0000178","MONDO_0002974","MONDO_0008903","EFO_0000182","MONDO_0016784","EFO_0002618","EFO_0005922","EFO_0003893","EFO_1001956","MONDO_0002108","MONDO_0008170","EFO_0005842","EFO_1002017","EFO_0002939","EFO_1001968","EFO_0005221","EFO_0009708","MONDO_0002691","MONDO_0015917","EFO_0001061","MONDO_0000544","EFO_0005537","EFO_0004284","EFO_0000574","EFO_0002938","MONDO_0021117","MONDO_0007254","EFO_0001071","EFO_0004252","EFO_0000708","MONDO_0021063","EFO_0000231","MONDO_0001056","EFO_1001480","EFO_0003860","EFO_0000326","EFO_0000707","HP_0001541","EFO_0000616","EFO_0003897","EFO_0006859","EFO_0002916","EFO_0000503","EFO_0000403","MONDO_0007576","EFO_0000313","EFO_0003060","EFO_0000311","EFO_1001961","EFO_0000211","EFO_0000702","EFO_0004142","MONDO_0003219","EFO_0000691","EFO_0000181"],"count":64},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL3186613","canonicalSmiles":"C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.CI","inchiKey":"DNRDQDFJZUHVNJ-STHHAXOLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186613","maximumClinicalTrialPhase":0,"parentId":"CHEMBL80","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205578"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL33","canonicalSmiles":"C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23","inchiKey":"GSDSWSVVBLHKDQ-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LEVOFLOXACIN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Evoxil","Floxacin","Iquix","Levaquin","Levofloxacin","Oftaquix","Quinsair","Quixin","Tavanic"],"synonyms":["DR-3355","Levofloxacin","Levofloxacin hemihydrate","Levofloxacin hydrate","Ofloxacin s-(-)-form","Ofloxacin s-(-)-form hemihydrate","RWJ-25213"],"crossReferences":{"DailyMed":["levofloxacin"],"PubChem":["26719895","49665952"],"Wikipedia":["Levofloxacin"],"drugbank":["DB01137"],"chEBI":["63598"]},"childChemblIds":["CHEMBL2237108"],"count":39,"approvedIndications":["EFO_0003106","EFO_0003103","EFO_0000771","EFO_0000544","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 5 approved and 34 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3349878","canonicalSmiles":"CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].[Na+]","inchiKey":"VVRPOCPLIUDBSA-CNZCJKERSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3349878","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1487","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL337612","canonicalSmiles":"O=C1CN2C(=O)CCC2N1","inchiKey":"XTXXOHPHLNROBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMIRACETAM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimiracetam","NT-11624"],"crossReferences":{"Wikipedia":["Dimiracetam"],"drugbank":["DB13018"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545156","drugType":"Small molecule","blackBoxWarning":false,"name":"KW-2450","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KW-2450","Kw-2450"],"count":2,"linkedTargets":{"rows":["ENSG00000140443","ENSG00000171105"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545165","canonicalSmiles":"O=C1Nc2ccccc2C(c2ccccc2)N1C1CCN(Cc2cccc(OC(F)(F)F)c2)CC1","inchiKey":"IJUMFEAYOMCXAQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFACIFENACIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afacifenacin","NS-986","Smp-986"],"count":1,"linkedTargets":{"rows":["ENSG00000185313","ENSG00000180720","ENSG00000184984","ENSG00000133019","ENSG00000181072","ENSG00000168356","ENSG00000168539"],"count":7},"linkedDiseases":{"rows":["EFO_1000781"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545279","canonicalSmiles":"Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N.Cl.Cl","inchiKey":"WFIOHOJEIMQCEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFATUTAZONE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3545280","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-7017","Efatutazone hydrochloride","RS5444"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545423","canonicalSmiles":"NC1CCCN(c2c(/C=C3/SC(=O)NC3=O)cccc2-c2ccccc2)C1","inchiKey":"MCUJKPPARUPFJM-LDADJPATSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-1208","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd 1208","Azd-1208"],"count":2,"linkedTargets":{"rows":["ENSG00000102096","ENSG00000137193","ENSG00000198355"],"count":3},"linkedDiseases":{"rows":["EFO_0000574","EFO_0000222"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3549142","canonicalSmiles":"NC[C@H]1OB(O)c2c(OCCCO)cccc21","inchiKey":"FXQIIDINBDJDKL-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPETRABOROLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AN-3365","AN3365","An3365","Epetraborole","GSK-2251052","GSK2251052","Gsk2251052"],"crossReferences":{"drugbank":["DB11744"]},"childChemblIds":["CHEMBL3527377","CHEMBL3527376"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707327","drugType":"Antibody","blackBoxWarning":false,"name":"SUPTAVUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-2222","REGN2222","SAR-438584","SAR438584","Suptavumab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL375655","canonicalSmiles":"Nc1nc2c(ncn2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"NYHBQMYGNKIUIF-UUOKFMHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANOSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guanosine"],"crossReferences":{"PubChem":["26754281"],"Wikipedia":["Guanosine"],"drugbank":["DB02857"],"chEBI":["16750"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3786098","canonicalSmiles":"C=CC(=O)N1C[C@H](COc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)[C@@H](OC)C1","inchiKey":"ODMXWZROLKITMS-RISCZKNCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06459988","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06459988","Pf-06459988"],"crossReferences":{"drugbank":["DB14768"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3822773","canonicalSmiles":"O=C(O)c1ccc([C@H]2C[C@@H]2c2ccc(OCc3c(-c4c(Cl)cccc4Cl)noc3C3CC3)cc2Cl)cc1","inchiKey":"XBUXXJUEBFDQHD-NHCUHLMSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3822773","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15416"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833343","drugType":"Antibody","blackBoxWarning":false,"name":"VOBARILIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALX-0061","ALX0061","Vobarilizumab"],"count":2,"linkedTargets":{"rows":["ENSG00000160712"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002690"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL385178","canonicalSmiles":"O=C(Nc1ccc(Oc2ccccc2)cc1)c1cccnc1NCc1ccncc1","inchiKey":"CPVRYQAOUPSUDO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL385178","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07183"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL388978","canonicalSmiles":"CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4","inchiKey":"HKSZLNNOFSGOKW-FYTWVXJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STAUROSPORINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["125299371","134959007","172131318","26755744","26755745"],"drugbank":["DB02010"],"chEBI":["15738"]},"childChemblIds":["CHEMBL3436363"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3931971","canonicalSmiles":"COC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(NS(=O)(=O)O)cc1)c1csc(-c2cccs2)n1","inchiKey":"KWJDHELCGJFUHW-SFTDATJTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAZUPROTAFIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AKB-9778","Razuprotafib"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL398707","canonicalSmiles":"CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5","inchiKey":"WVLOADHCBXTIJK-YNHQPCIGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HYDROMORPHONE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dilaudid","Dilaudid-HP","Hydromorphone","IDS-NH-004","N02AA03","NSC-19046","Palladone"],"crossReferences":{"DailyMed":["hydromorphone%20hydrochloride"],"Wikipedia":["Hydromorphone"],"drugbank":["DB00327"],"chEBI":["5790"]},"childChemblIds":["CHEMBL3989585","CHEMBL1237055"],"count":12,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","EFO_0004240","HP_0012532","Orphanet_232","EFO_0003821","MONDO_0004567","HP_0003418","EFO_0010702","EFO_0003843","EFO_0000311","HP_0002018","MONDO_0001416","EFO_0000546","EFO_0003890","EFO_1000786","EFO_1001898","EFO_0001421","EFO_0004616","HP_0003419","EFO_0003766","EFO_0005611","HP_0002019"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for pain and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL398940","canonicalSmiles":"NCCNCCN1CC1","inchiKey":"XJNAQZHMIAKQOK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL398940","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15643"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989507","canonicalSmiles":"O.O.O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)O)CC(=O)O.[Na+].[Na+]","inchiKey":"OVBJJZOQPCKUOR-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"EDETATE DISODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1749","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Disodium edetate","Edetate disodium","Endrate","Sodium versenate"],"synonyms":["Disodium edetate","Edetate disodium","Ethylenediaminetetraacetate","Ethylenedinitrilotetraacetate disodium","Sodium edetate"],"count":1,"approvedIndications":["EFO_0003966"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for eye disease."}
{"id":"CHEMBL3989556","canonicalSmiles":"CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC.Cl.O","inchiKey":"SPFVHFBNXPARTR-IDMXKUIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMOXIPRIDE HYDROCHLORIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL22242","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Hematological toxicity"],"year":1993},"tradeNames":["Roxiam","Roxiam ir"],"synonyms":["A 33547.HCL.H20","FLA 731(-)","Remoxipride hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990. It was withdrawn in United Kingdom  in 1993 due to Hematological toxicity."}
{"id":"CHEMBL3989924","drugType":"Unknown","blackBoxWarning":false,"name":"LUTETIUM DOTATATE LU-177","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3991432","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lutathera"],"synonyms":["177lu-dota-tyr3-octreotate","177lu-dotatate","Lutetium (177lu) oxodotreotide","Lutetium dotatate lu-177","Lutetium lu 177 dotatate","Lutetium oxodotreotide lu-177"],"crossReferences":{"DailyMed":["lutetium%20dotatate%20lu-177"]},"count":4,"approvedIndications":["EFO_1001901"],"linkedTargets":{"rows":["ENSG00000162009","ENSG00000132671","ENSG00000278195","ENSG00000139874","ENSG00000180616"],"count":5},"linkedDiseases":{"rows":["MONDO_0002120","EFO_1001901","MONDO_0024503","Orphanet_2495","EFO_0000621","EFO_1000045"],"count":6},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for neuroendocrine neoplasm and has 3 investigational indications."}
{"id":"CHEMBL3990048","drugType":"Enzyme","blackBoxWarning":true,"name":"VESTRONIDASE ALFA-VJBK","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mepsevii"],"synonyms":["Vestronidase alfa-vjbk"],"count":1,"approvedIndications":["Orphanet_584"],"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2017 and is indicated for mucopolysaccharidosis type 7. This drug has a black box warning from the FDA."}
{"id":"CHEMBL404431","canonicalSmiles":"CC(C)(N)CNC(=O)C[C@H]1CC[C@]2(CC1)OO[C@]1(O2)C2CC3CC(C2)CC1C3","inchiKey":"VXYZBLXGCYNIHP-CAGINOIPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OZ277","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OZ-277","Oz277"],"childChemblIds":["CHEMBL570680"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4097197","canonicalSmiles":"CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1.CS(=O)(=O)O.CS(=O)(=O)O","inchiKey":"RFRIKACSFOTIMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4097197","maximumClinicalTrialPhase":0,"parentId":"CHEMBL521851","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4116008","canonicalSmiles":"CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1","inchiKey":"BGLPECHZZQDNCD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4116008","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15499"]},"childChemblIds":["CHEMBL3991929"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL416755","canonicalSmiles":"CCn1cc(C(=O)O)c(=O)c2cc3c(cc21)OCO3","inchiKey":"KYGZCKSPAKDVKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXOLINIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Utibid"],"synonyms":["Oxolinic acid","W 4565"],"crossReferences":{"PubChem":["104171206","11111565","11111566","144203767","144209985","26747409","26747410","50100298","50105701","50105702","85231164","855760","90340649"],"Wikipedia":["Oxolinic_acid"],"drugbank":["DB13627"],"chEBI":["138856"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4216467","canonicalSmiles":"CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21","inchiKey":"CEFJVGZHQAGLHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIPRETINIB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Qinlock"],"synonyms":["DCC-2618","Dcc-2618","Ripretinib"],"crossReferences":{"DailyMed":["ripretinib"],"drugbank":["DB14840"]},"count":1,"approvedIndications":["Orphanet_44890"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000157404"],"count":2},"linkedDiseases":{"rows":["Orphanet_44890"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for gastrointestinal stromal tumor."}
{"id":"CHEMBL4244843","canonicalSmiles":"C=CC(C)(C)OC[C@H]1O[C@H](O[C@@H]2C3=C([C@H](C)COC(C)=O)C[C@H](O)[C@]3(C)/C=C3/[C@@H](COC)CC[C@H]3[C@@H](C)[C@H]2O)[C@H](O)[C@@H](OC(C)=O)[C@@H]1O","inchiKey":"KXTYBXCEQOANSX-WYKQKOHHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4244843","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01780"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297329","canonicalSmiles":"C[C@]1(O)C[C@@](N)(c2ccc(-c3nc4n(c3-c3ccccc3)COc3ccncc3-4)cc2)C1","inchiKey":"AIFGVDXMHWGOGJ-DIVCQZSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAS-117","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAS 117","Tas-117"],"crossReferences":{"drugbank":["DB15054"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297344","canonicalSmiles":"FC(F)(F)Oc1ccc(Nc2ccc3cccc(Cl)c3n2)cc1","inchiKey":"OZOGDCZJYVSUBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABX-464","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABX464","Abx-464","Abx464","SPL-464"],"crossReferences":{"drugbank":["DB14828"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297586","canonicalSmiles":"CN(CC(=O)Nc1nc2ccc(OC(F)(F)F)cc2s1)C(=O)CNC(=O)CN","inchiKey":"YBZSGIWIPOUSHY-UHFFFAOYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"TRORILUZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BHV-4157a","Troriluzole"],"crossReferences":{"drugbank":["DB15079"]},"childChemblIds":["CHEMBL4297673"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297625","canonicalSmiles":"CCc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc2c(c1)OCCO2","inchiKey":"XFJAMQQAAMJFGB-ZQGJOIPISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LICOGLIFLOZIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LIK-066","LIK066","Licogliflozin","Lik066"],"crossReferences":{"drugbank":["DB15048"]},"count":5,"linkedTargets":{"rows":["ENSG00000140675","ENSG00000100170"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003095","EFO_0001360","EFO_0001073","EFO_0000660"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297663","canonicalSmiles":"Cn1c(=O)c2c(ncn2CC(=O)O)n(C)c1=O.Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1","inchiKey":"IPUHJDQWESJTGD-PFWPSKEQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMBROXOL ACEFYLLINATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acebrophylline","Ambroxol acefyllinate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297775","drugType":"Unknown","blackBoxWarning":false,"name":"KAI-1678","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KP-1678","Kai-1678"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297882","drugType":"Unknown","blackBoxWarning":false,"name":"FIMAPORFIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amphinex","Fimaporfin"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297978","drugType":"Unknown","blackBoxWarning":false,"name":"BTI-410","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTI-410","Bti-410","Hip2b"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297980","drugType":"Unknown","blackBoxWarning":false,"name":"HM-43239","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HM-43239","HM43239","Hm-43239","Hm43239"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4301163","canonicalSmiles":"CCC(=O)NS(=O)(=O)c1ccc(NC(=O)Cc2ccc(Br)c(Oc3cc(Cl)cc(C#N)c3)c2F)c(Cl)c1","inchiKey":"ULTDEARCBRNRGR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELSULFAVIRINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elsulfavirine"],"crossReferences":{"drugbank":["DB14929"]},"childChemblIds":["CHEMBL4297377"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4303635","canonicalSmiles":"NCCCC[C@H](N)C(=O)O.N[C@@H](CSCC(=O)O)C(=O)O.O","inchiKey":"QVJUWKMADMJHJZ-PBUQCQDLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4303635","maximumClinicalTrialPhase":0,"parentId":"CHEMBL396416","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL431651","canonicalSmiles":"CCCOc1ccc2c(c1)[C@@H](c1ccc(OC)cc1OCCO)[C@H](C(=O)O)[C@H]2c1ccc2c(c1)OCO2","inchiKey":"GLCKXJLCYIJMRB-UPRLRBBYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENRASENTAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enrasentan","SB-217242","Sb-217242"],"crossReferences":{"drugbank":["DB06460"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL432162","canonicalSmiles":"Cc1nc(C)c2c(n1)N(Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CC2","inchiKey":"ADXGNEYLLLSOAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TASOSARTAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANA-756","Tasosartan","WAY-ANA-756"],"crossReferences":{"drugbank":["DB01349"]},"count":1,"linkedTargets":{"rows":["ENSG00000144891"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL435224","canonicalSmiles":"COc1cccc([C@H]2O[C@H](CC(=O)N3CCC(CC(=O)O)CC3)C(=O)N(CC(C)(C)COC(C)=O)c3ccc(Cl)cc32)c1OC","inchiKey":"CMLUGNQVANVZHY-POURPWNDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LAPAQUISTAT ACETATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lapaquistat acetate","TAK 475","TAK-475"],"count":4,"linkedTargets":{"rows":["ENSG00000079459"],"count":1},"linkedDiseases":{"rows":["HP_0003124","EFO_0003774","EFO_0001360","Orphanet_309005"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL443732","canonicalSmiles":"NC(N)=NOCC[C@H](N)C(=O)O","inchiKey":"FSBIGDSBMBYOPN-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANAVANINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Canavanine","L-Canavanine Sulfate"],"crossReferences":{"PubChem":["11111008","11113636","50104536","50104537","90341177"],"drugbank":["DB01833"],"chEBI":["609827"]},"childChemblIds":["CHEMBL1741898","CHEMBL1551643"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL455333","canonicalSmiles":"Nc1ccc2c(c1)c(-c1ccccc1)[n+](CCCCCCc1cn(CCNc3c4c(nc5ccccc35)CCCC4)nn1)c1cc(N)ccc21","inchiKey":"NAARZDJZGYBXKL-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL455333","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02226"]},"childChemblIds":["CHEMBL540657"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL457526","canonicalSmiles":"N#Cc1ccc(COc2ccc3cc(S(=O)(=O)N[C@H](CCC(=O)O)C(=O)O)ccc3c2)c(F)c1","inchiKey":"IRJUSGUHNFMVCK-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL457526","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08112"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL457530","canonicalSmiles":"CN(C)C(=N)NCCC[C@H](N)C(=O)O","inchiKey":"YDGMGEXADBMOMJ-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL457530","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111070","90341201"],"Wikipedia":["Asymmetric_dimethylarginine"],"drugbank":["DB01686"],"chEBI":["17929"]},"childChemblIds":["CHEMBL1255836"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594308","drugType":"Gene","blackBoxWarning":false,"name":"OLVIMULOGENE NANIVACIREPVEC","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GL-ONC1","Gl-onc1","Olvimulogene nanivacirepvec"],"count":3,"description":"Gene drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594447","canonicalSmiles":"CCCNCCOc1cc(F)cc(S(C)(=O)=O)c1","inchiKey":"OSBPYFBXSLJHCR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESDOPETAM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IRL-790","IRL790","Irl790","Mesdopetam"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594562","drugType":"Unknown","blackBoxWarning":false,"name":"ISIS-2503","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ISIS 2503","Isis 2503","Isis-2503"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL465","canonicalSmiles":"CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(C)=C[C@@H]21","inchiKey":"CYQFCXCEBYINGO-IAGOWNOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DRONABINOL","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dronabinol","Marinol","Syndros"],"synonyms":["ABBOTT 40566","ABBOTT-40566","Delta-9-tetrahydrocannabinol","Delta-9-thc","Dronabinol","J882F","NSC-134454","QCD 84924","QCD-84924","SP 104","SP-104","Tetrahydrocannabinols (-)-trans-.delta.9-form"],"crossReferences":{"DailyMed":["dronabinol"],"PubChem":["144206169"],"Wikipedia":["Tetrahydrocannabinol"],"drugbank":["DB00470"],"chEBI":["66964"]},"count":30,"approvedIndications":["EFO_0006911","HP_0002018"],"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["Orphanet_232","EFO_0000555","HP_0000726","EFO_0000249","EFO_0003778","EFO_0003829","HP_0002018","EFO_0007191","HP_0100543","EFO_0000289","EFO_0005295","EFO_0004616","EFO_0000253","HP_0012167","HP_0100749","EFO_0000692","EFO_0004215","EFO_0005296","HP_0012532","EFO_0006911","EFO_0004329","HP_0000473","EFO_0001358","EFO_0003843","EFO_0003885","EFO_0003890","EFO_0010282","HP_0003040","EFO_0004895","EFO_0000764","EFO_0005611","EFO_0003918","EFO_0003108"],"count":33},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for nausea and chemotherapy-induced nausea and vomiting and has 28 investigational indications."}
{"id":"CHEMBL46618","canonicalSmiles":"COC(=O)[C@H](Cc1cccc(C(=N)N)c1)[C@@H](C)NC(=O)c1ccc(-c2cc[n+]([O-])cc2)cc1","inchiKey":"PFGVNLZDWRZPJW-OPAMFIHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OTAMIXABAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FXV-673","Otamixaban","RPR-130673","RPR130673","XRP-0673","XRP0673"],"crossReferences":{"Wikipedia":["Otamixaban"],"drugbank":["DB06635"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL478629","canonicalSmiles":"c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1","inchiKey":"XHBVYDAKJHETMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORSOMORPHIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dorsomorphin"],"crossReferences":{"PubChem":["124893194","29217627"],"drugbank":["DB08597"],"chEBI":["78510"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489657","canonicalSmiles":"Cc1cccc(C)c1C(=O)Nc1cc(Br)c(O)c(Br)c1","inchiKey":"IFECSMFQARKPSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL489657","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07693"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL492","canonicalSmiles":"CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C","inchiKey":"VTUSIVBDOCDNHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIDOCAINE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Duranest [as hydrochloride]"],"synonyms":["Etidocaine","W-19053","W-19053 [AS HYDROCHLORIDE]"],"crossReferences":{"PubChem":["144206521"],"Wikipedia":["Etidocaine"],"drugbank":["DB08987"],"chEBI":["4904"]},"childChemblIds":["CHEMBL1200597"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL500853","canonicalSmiles":"CCCCCCOC(C)c1c(C)c2cc3nc(c4c5[nH]c(cc6nc(cc1[nH]2)C(C)=C6CC)c(C)c5C(=O)C4)[C@@H](CCC(=O)O)[C@@H]3C","inchiKey":"PVXGCBZIVFCMJK-NMWXTPPCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HPPH","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hpph"],"crossReferences":{"drugbank":["DB15243"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL50444","canonicalSmiles":"CC(O)(CC(=O)O)CC(=O)O","inchiKey":"NPOAOTPXWNWTSH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEGLUTOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB-337","Meglutol"],"crossReferences":{"Wikipedia":["Meglutol"],"drugbank":["DB04377"],"chEBI":["16831"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL514432","canonicalSmiles":"C[C@@H]1C(=O)O[C@H]2[C@H](O)[C@@]34[C@H]5C[C@@H](C(C)(C)C)[C@]36[C@@H](OC(=O)[C@@H]6O)O[C@@]4(C(=O)O5)[C@@]12O","inchiKey":"SQOJOAFXDQDRGF-MMQTXUMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GINKOLIDE B","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49664977"],"drugbank":["DB06744"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL519374","canonicalSmiles":"CO[C@@]1(NC(=O)[C@H](C(=O)O)c2ccc(O)cc2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CO[C@@H]21","inchiKey":"JWCSIUVGFCSJCK-LIUKBUMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL519374","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04342"]},"childChemblIds":["CHEMBL4303378"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL526","canonicalSmiles":"CC(C)c1cccc(C(C)C)c1O","inchiKey":"OLBCVFGFOZPWHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPOFOL","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diprivan","Disoprivan","Propofol","Rapinovet"],"synonyms":["Disoprofol","ICI 35,868","ICI 35-868","ICI-35868","ICI35,868","NSC-5105","Propofol"],"crossReferences":{"DailyMed":["propofol"],"PubChem":["104171149","11111121","11111122","124879991","144203685","144208569","144213542","170464994","17389856","26747380","47193694","50105615","90341256"],"Wikipedia":["Propofol"],"drugbank":["DB00818"],"chEBI":["44915"]},"childChemblIds":["CHEMBL356637","CHEMBL154232"],"count":44,"linkedTargets":{"rows":["ENSG00000109158","ENSG00000145863","ENSG00000187730","ENSG00000011677","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000022355","ENSG00000102287","ENSG00000182256","ENSG00000094755","ENSG00000268089","ENSG00000163285","ENSG00000113327","ENSG00000186297","ENSG00000163288"],"count":16},"linkedDiseases":{"rows":["EFO_0003869","EFO_0003777","HP_0000989","EFO_0007486","EFO_0000275","MONDO_0002009","HP_0001298","EFO_0003855","EFO_0005773","EFO_0004698","EFO_1001951","EFO_0003829","EFO_0000565","HP_0100543","HP_0025425","EFO_0003931","EFO_0002506","EFO_0003870","EFO_0000544","MONDO_0008903","EFO_0003884","EFO_0000692","EFO_1001250","EFO_0008526","EFO_0002618","EFO_0001074","HP_0002093","EFO_0009447","EFO_0002687","EFO_0005323","EFO_0002508","HP_0001919","EFO_0003821","EFO_0000662","HP_0100806","EFO_0001422","MP_0001845","EFO_0000546","HP_0002045","MONDO_0100096","EFO_0004888","HP_0001336","EFO_0005109","EFO_0009659","HP_0025428","HP_0031273","EFO_0003767","EFO_0005251","MONDO_0018373","EFO_0003086","EFO_0001059","EFO_0006834","EFO_1001905","MONDO_0021117","EFO_1001454","EFO_0009267","EFO_1000637","EFO_1001311","EFO_1002048","MONDO_0024355","EFO_0002950","MONDO_0002050","EFO_1001801","HP_0030834","EFO_0000712","HP_0002017","EFO_0003839","EFO_0009854","EFO_0003917","EFO_0000616","EFO_0000694","EFO_0009551","EFO_0005774","HP_0000486","EFO_0004210","EFO_0004329","EFO_0003832","EFO_0001645","EFO_0005207","HP_0011110","MONDO_0007576","HP_0003418","MONDO_0004379","EFO_0001073","EFO_0003843","EFO_0009549","EFO_0002615","EFO_0000311","HP_0000713","EFO_0000537","EFO_0001072","EFO_0000713","EFO_0003890","EFO_0010282","EFO_0004273","MONDO_0002367","MONDO_0043510","EFO_0003918","EFO_0004259"],"count":99},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 44 investigational indications."}
{"id":"CHEMBL543336","canonicalSmiles":"CN[C@H]1CN(c2ccc3c(=O)c(C(=O)O)cn(-c4nccs4)c3n2)C[C@@H]1OC.Cl","inchiKey":"JJZCCQHWCOXGCL-QNTKWALQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL543336","maximumClinicalTrialPhase":0,"parentId":"CHEMBL68117","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL547","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C\\C(=O)O)C(C)(C)CCC1","inchiKey":"SHGAZHPCJJPHSC-XFYACQKRSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ISOTRETINOIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Absorica","Absorica ld","Accutane","Amnesteem","Claravis","Isotrex","Myorisan","Roaccutane","Sotret","Zenatane"],"synonyms":["13 Cis-Retinoic Acid","Isotretinoin","PAT-001","RO 4-3780","RO-4-3780","RO-43780","Retinoic acid 13-cis-form"],"crossReferences":{"DailyMed":["isotretinoin"],"PubChem":["144207291","26747659","26753641","26753642","26753643","26753644","47193696","50106981","90341473"],"Wikipedia":["Isotretinoin"],"drugbank":["DB00982"],"chEBI":["6067"]},"count":44,"approvedIndications":["EFO_0003894"],"linkedTargets":{"rows":["ENSG00000131759","ENSG00000077092","ENSG00000172819"],"count":3},"linkedDiseases":{"rows":["EFO_1000910","MONDO_0000873","EFO_1000764","EFO_0000681","EFO_0000249","MONDO_0019269","EFO_1001465","EFO_0000464","EFO_1001129","EFO_1000690","EFO_0000565","EFO_0000309","EFO_0000339","EFO_0000544","MONDO_0002974","MONDO_0003268","EFO_0000279","MONDO_0008903","EFO_0000330","EFO_0002499","EFO_0000183","EFO_1000158","EFO_0000198","EFO_0000616","EFO_0006859","EFO_0000180","EFO_1001006","EFO_0000403","EFO_0000222","EFO_0002939","EFO_1000309","EFO_0000502","MONDO_0000870","EFO_0004236","EFO_0002501","EFO_0003894","EFO_0000224","EFO_0000621","EFO_0007512","MONDO_0008315","EFO_0002496","EFO_1000760","MONDO_0100096","MONDO_0002367","EFO_1001051","EFO_0001378","EFO_0003833","EFO_0000519","MONDO_0021640"],"count":49},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for acne and has 43 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL56564","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)c1c[nH]c3ccccc13)C2","inchiKey":"ZNRGQMMCGHDTEI-ITGUQSILSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROPISETRON","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Navoban"],"synonyms":["ICS-205-930","Tropisetron"],"crossReferences":{"PubChem":["26755041"],"drugbank":["DB11699"],"chEBI":["32269"]},"childChemblIds":["CHEMBL3348564","CHEMBL2130744"],"count":2,"approvedIndications":["HP_0002018"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for nausea and has 1 investigational indication."}
{"id":"CHEMBL569713","canonicalSmiles":"CN1[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21","inchiKey":"STECJAGHUSJQJN-FWXGHANASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCOPOLAMINE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isoptpo Hyoscine","Scopolamine","Transderm scop"],"synonyms":["Scopolamine"],"crossReferences":{"DailyMed":["scopolamine"],"drugbank":["DB00747"],"chEBI":["16794"]},"childChemblIds":["CHEMBL2251240","CHEMBL3185877","CHEMBL1530287","CHEMBL1877254"],"count":10,"approvedIndications":["EFO_0004888","HP_0002018"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["EFO_0006928","MONDO_0002009","HP_0000726","EFO_0000249","EFO_1001917","EFO_0003843","HP_0002018","EFO_1001412","EFO_0000289","MONDO_0002050","EFO_0010282","EFO_0000544","EFO_0005758","EFO_0009431","EFO_0004888","EFO_1000632","EFO_0003761","EFO_0000253","EFO_0003766","HP_0002307"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and is indicated for nausea and post operative nausea and vomiting and has 8 investigational indications."}
{"id":"CHEMBL570533","canonicalSmiles":"Cc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1","inchiKey":"JONFDFIXMPXTRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL570533","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07267"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL692","canonicalSmiles":"OCC(O)CO","inchiKey":"PEDCQBHIVMGVHV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCERIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glycerol","Glycogelatin","Keybells","Nirolex","Ophthalgan","Optim","Osmoglyn","Senokot direct relief","Tixylix baby","Tixylix toddler","Waterhouse"],"synonyms":["E-422","E422","FEMA NO. 2525","Glycerin","Glycerol","Glycerol 85%","INS NO.422","INS-422","M 314429","Monoctanoin Component D","Monoctanoin component d","NSC-9230","PZN 7474853"],"crossReferences":{"DailyMed":["glycerin"],"PubChem":["144204594","144209275","144210464","17388987","17389867","29215106"],"Wikipedia":["Glycerol"],"drugbank":["DB09462"],"chEBI":["17754"]},"count":11,"approvedIndications":["HP_0002019","EFO_0003785"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for allergy and constipation and has 9 investigational indications."}
{"id":"CHEMBL709","canonicalSmiles":"COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC","inchiKey":"WNMJYKCGWZFFKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALFUZOSIN","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Alfuzosin","Uroxatral"],"crossReferences":{"DailyMed":["alfuzosin%20hydrochloride"],"PubChem":["174007387","26719847","26749009","26749010","50107503","50107504","90341616"],"Wikipedia":["Alfuzosin"],"drugbank":["DB00346"],"chEBI":["51141"]},"childChemblIds":["CHEMBL1723"],"count":6,"approvedIndications":["EFO_0000284"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0003885","EFO_1001412","HP_0000016","EFO_0004253","EFO_1001228","EFO_0000284","EFO_0003830","HP_0000011","HP_0002019"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for benign prostatic hyperplasia and has 5 investigational indications."}
{"id":"CHEMBL73822","canonicalSmiles":"Cn1c(/C=C/CO)c(CO)c2c1C(=O)C=C(N1CC1)C2=O","inchiKey":"MXPOCMVWFLDDLZ-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APAZIQUONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apaziquone","EO-9","EO9","NOR-701","NSC-382456","NSC-382459"],"crossReferences":{"PubChem":["470867"],"Wikipedia":["Apaziquone"],"drugbank":["DB12593"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL8211","canonicalSmiles":"CCN1C(=O)C=CC1=O","inchiKey":"HDFGOPSGAURCEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"N-ETHYLMALEIMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111152","50106270","85231035","90341440"],"Wikipedia":["N-Ethylmaleimide"],"drugbank":["DB02967"],"chEBI":["44485"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL871","canonicalSmiles":"CC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"DBVJJBKOTRCVKF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIDRONIC ACID","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Didronel","Etidronate","Etidronic acid","M05BA01","NSC-227995"],"crossReferences":{"PubChem":["144207615","29215269","93576729"],"Wikipedia":["Etidronic_acid"],"drugbank":["DB01077"],"chEBI":["4907"]},"childChemblIds":["CHEMBL1874205","CHEMBL1201042"],"count":1,"approvedIndications":["EFO_0004260"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977 and is indicated for bone disease."}
{"id":"CHEMBL876","canonicalSmiles":"Cc1ccc(Cl)c(Nc2ccccc2C(=O)[O-])c1Cl.[Na+]","inchiKey":"OGPIIGMUPMPMNT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"MECLOFENAMATE SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL509","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Meclodium","Meclofenamate Sodium","Meclomen"],"synonyms":["CL-583"],"crossReferences":{"PubChem":["11112050","124881881","26732642","26747562","50106545","85231313","855858"],"chEBI":["6711"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL93647","canonicalSmiles":"NC(N)=Nc1nc(-c2ccc(CNc3nc4ccccc4[nH]3)s2)cs1","inchiKey":"CKJGKHXCUDWFDC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL93647","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02616"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
